News

May 20, 2022

Paresh Vyas, MRCP FRCP FRCPath

Paresh Vyas, MRCP FRCP FRCPath, is a Professor of Haematology at Oxford University. He studied medicine at Cambridge then Oxford. After completing his medical and haematology  training in London. He did his PhD with Professor Higgs and Professor Sir Weatherall at the MRC Molecular Haematology Unit, Oxford and did a three years doing a post-doctoral…

May 20, 2022

Matthew Vander Heiden, MD, PhD

Matthew Vander Heiden, M.D., Ph.D., is an Associate Professor in the Department of Biology at the Massachusetts Institute of Technology, and Associate Director of the Koch Institute for Integrative Cancer Research.  He is also an HHMI Faculty Scholar, an Institute Member of the Broad Institute of Harvard and MIT, and an Instructor of Medicine at…

May 20, 2022

George Thomas, MD

Dr. George Thomas is a professor of pathology at the Knight Cancer Institute, Oregon Health & Science University in Portland, Oregon. He is also associate medical director of the Knight Diagnostics Laboratory. His clinical area of expertise is in precision oncology of prostate and kidney cancers. He directs a translational research program that studies treatment…

May 20, 2022

Shin-San Michael Su, PhD

Dr. Michael Su joined Volastra as Chief Scientific Officer in February 2020. Previously, he served as CSO of Decibel Therapeutics, a gene therapy company focused on hearing loss and imbalance between 2016 and 2020.  Michael was a co-founder and Senior Vice President of Research and Development at Agios Pharmaceuticals between 2008 and 2016. During his…

May 20, 2022

Eytan Stein, MD

Eytan M. Stein, MD is an Associate Attending Physician, Clinical Investigator and Director of the Program for Drug Development in Leukemia on the Leukemia Service at Memorial Sloan Kettering Cancer Center. He conducts novel, phase I clinical trials of compounds that target the genetic and epigenetic basis of myeloid malignancies. Dr. Stein led the clinical…

May 20, 2022

Kimberly Stegmaier, MD

Kimberly Stegmaier, MD, Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric malignancies. She is the Vice Chair for Pediatric Oncology Research, Co-director of the Pediatric Hematologic Malignancy Program, and an attending physician providing…

May 20, 2022

Mikhail (Misha) Roshal, MD, PhD

Misha Roshal is a practicing hematopathologist, associate attending physician, and director of the clinical flow cytometry laboratory in the department of pathology in Memorial Sloan Kettering Cancer Center. His major clinical expertise is in development of robust flow cytometry-based assays for assessment of treatment response of hematologic neoplasms.  His laboratory has developed assays for high sensitivity…

May 20, 2022

Thomas Graeber, PhD

Thomas Graeber, PhD, is a Professor in the Department of Molecular & Medical Pharmacology, and the Director of the UCLA Metabolomics Center. Thomas Graeber received his B.S. in Physics from UCLA (1990) and his PhD in Physics/Cancer Biology from Stanford University (1996) with Amato Giaccia studying the role of p53 in hypoxia-induced apoptosis. He is…